{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:21:22Z","timestamp":1791278482432,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1124\/jpet.113.203364","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T05:19:11Z","timestamp":1363238351000},"page":"250-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium\/Glucose Cotransporter 1 (SGLT1)\u2013Mediated Absorption of Intestinal Glucose"],"prefix":"10.1016","volume":"345","author":[{"given":"David R.","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"DaCosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faika","family":"Mseeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie K.","family":"Shadoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Sands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Zambrowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.203364_bib1","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.2337\/db10-0098","article-title":"Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans","volume":"59","author":"Asmar","year":"2010","journal-title":"Diabetes"},{"key":"10.1124\/jpet.113.203364_bib2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.113.203364_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","article-title":"Gut hormone PYY(3-36) physiologically inhibits food intake","volume":"418","author":"Batterham","year":"2002","journal-title":"Nature"},{"key":"10.1124\/jpet.113.203364_bib4","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/oby.2008.361","article-title":"High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes","volume":"16","author":"Brommage","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/jpet.113.203364_bib5","first-page":"G1415","article-title":"Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat","volume":"275","author":"Cherbut","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.113.203364_bib6","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2337\/db08-0958","article-title":"Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes","volume":"58","author":"Chia","year":"2009","journal-title":"Diabetes"},{"key":"10.1124\/jpet.113.203364_bib56","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/ijo.2009.15","article-title":"Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery","volume":"33 (Suppl 1)","author":"Cummings","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1124\/jpet.113.203364_bib7","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1185\/03007990802418851","article-title":"Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study","volume":"24","author":"DeFronzo","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/jpet.113.203364_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1463-1326.2012.01558.x","article-title":"Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin","volume":"14","author":"Devineni","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.113.203364_bib9","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1128\/MCB.21.14.4829-4836.2001","article-title":"Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN","volume":"21","author":"Donoviel","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.113.203364_bib10","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1210\/endo.139.9.6202","article-title":"Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum","volume":"139","author":"Dumoulin","year":"1998","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.113.203364_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/dmrr.532","article-title":"Phlorizin: a review","volume":"21","author":"Ehrenkranz","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1124\/jpet.113.203364_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2362.1992.tb01464.x","article-title":"Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man","volume":"22","author":"Eissele","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.113.203364_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1380159","article-title":"Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns","volume":"138","author":"Elliott","year":"1993","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.113.203364_bib14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.113.203364_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF00374378","article-title":"Peptide YY release after intraduodenal, intraileal, and intracolonic administration of nutrients in rats","volume":"431","author":"Fu-Cheng","year":"1995","journal-title":"Pflugers Arch"},{"key":"10.1124\/jpet.113.203364_bib16","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1021\/jm900951n","article-title":"Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes","volume":"52","author":"Goodwin","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.113.203364_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/db11-1029","article-title":"Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion","volume":"61","author":"Gorboulev","year":"2012","journal-title":"Diabetes"},{"key":"10.1124\/jpet.113.203364_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000201231","article-title":"Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients","volume":"56","author":"Herrmann","year":"1995","journal-title":"Digestion"},{"key":"10.1124\/jpet.113.203364_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.113.203364_bib20","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc09-0459","article-title":"Projecting the future diabetes population size and related costs for the U.S","volume":"32","author":"Huang","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.113.203364_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2007.10.001","article-title":"Polymer-phloridzin conjugates as an anti-diabetic drug that inhibits glucose absorption through the Na+\/glucose cotransporter (SGLT1) in the small intestine","volume":"125","author":"Ikumi","year":"2008","journal-title":"J Control Release"},{"key":"10.1124\/jpet.113.203364_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2337\/db10-1328","article-title":"SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function","volume":"60","author":"Jurczak","year":"2011","journal-title":"Diabetes"},{"key":"10.1124\/jpet.113.203364_bib23","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1210\/jc.2005-0409","article-title":"Peptide YY is secreted after oral glucose administration in a gender-specific manner","volume":"90","author":"Kim","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.113.203364_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.2008.250","article-title":"Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus","volume":"85","author":"Komoroski","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.113.203364_bib25","doi-asserted-by":"crossref","first-page":"e35240","DOI":"10.1371\/journal.pone.0035240","article-title":"Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.113.203364_bib26","doi-asserted-by":"crossref","first-page":"E1358","DOI":"10.1152\/ajpendo.00412.2009","article-title":"Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice","volume":"297","author":"Moriya","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.113.203364_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0167-0115(03)00125-3","article-title":"GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine","volume":"114","author":"Mortensen","year":"2003","journal-title":"Regul Pept"},{"key":"10.1124\/jpet.113.203364_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1124\/jpet.113.203364_bib29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/jn\/138.4.732","article-title":"Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast","volume":"138","author":"Nilsson","year":"2008","journal-title":"J Nutr"},{"key":"10.1124\/jpet.113.203364_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-008-1202-x","article-title":"Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells","volume":"52","author":"Parker","year":"2009","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.113.203364_bib31","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00439.2012","article-title":"Improved glycemic control in mice lacking Sglt1 and Sglt2","volume":"304","author":"Powell","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.113.203364_bib32","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"10.1124\/jpet.113.203364_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.idairyj.2009.11.014","article-title":"Molecular mechanisms underlying nutrient detection by incretin-secreting cells","volume":"20","author":"Reimann","year":"2010","journal-title":"Int Dairy J"},{"key":"10.1124\/jpet.113.203364_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cmet.2008.11.002","article-title":"Glucose sensing in L cells: a primary cell study","volume":"8","author":"Reimann","year":"2008","journal-title":"Cell Metab"},{"issue":"2","key":"10.1124\/jpet.113.203364_bib35","first-page":"CD006739","article-title":"Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus","author":"Richter","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.113.203364_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control","volume":"15","author":"Rodbard","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1124\/jpet.113.203364_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejpb.2010.04.003","article-title":"Carboxyl group-terminated polyamidoamine dendrimers bearing glucosides inhibit intestinal hexose transporter-mediated D-glucose uptake","volume":"75","author":"Sakuma","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.113.203364_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1463-1326.2011.01406.x","article-title":"Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects","volume":"13","author":"Sha","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/jpet.113.203364_bib39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.112.193045","article-title":"KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models","volume":"342","author":"Shibazaki","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203364_bib40","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1210\/en.2009-1332","article-title":"Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery","volume":"151","author":"Shin","year":"2010","journal-title":"Endocrinology"},{"issue":"10","key":"10.1124\/jpet.113.203364_bib41","first-page":"CD006423","article-title":"Glucagon-like peptide analogues for type 2 diabetes mellitus","author":"Shyangdan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/jpet.113.203364_bib42","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1152\/ajpendo.00326.2004","article-title":"Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP","volume":"290","author":"Theodorakis","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.113.203364_bib43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"key":"10.1124\/jpet.113.203364_bib44","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1124\/jpet.113.203364_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/jpet.113.203364_bib46","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/jpet.113.203364_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0167-0115(03)00111-3","article-title":"Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects","volume":"114","author":"Vilsb\u00f8ll","year":"2003","journal-title":"Regul Pept"},{"key":"10.1124\/jpet.113.203364_bib48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1464-5491.2002.00718.x","article-title":"Coefficient of failure: a methodology for examining longitudinal beta-cell function in Type 2 diabetes","volume":"19","author":"Wallace","year":"2002","journal-title":"Diabet Med"},{"key":"10.1124\/jpet.113.203364_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.113.203364_bib50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00424-003-1202-0","article-title":"The sodium\/glucose cotransport family SLC5","volume":"447","author":"Wright","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/jpet.113.203364_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3945\/ajcn.111.021543","article-title":"Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans","volume":"95","author":"Wu","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1124\/jpet.113.203364_bib52","doi-asserted-by":"crossref","first-page":"G476","DOI":"10.1152\/ajpgi.00432.2009","article-title":"Differential responses of the incretin hormones GIP and GLP-1 to increasing doses of dietary carbohydrate but not dietary protein in lean rats","volume":"299","author":"Yoder","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.113.203364_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/clpt.2012.58","article-title":"LX4211, a dual SGLT1\/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial","volume":"92","author":"Zambrowicz","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.113.203364_bib54","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/oby.2006.77","article-title":"Peptide YY and proglucagon mRNA expression patterns and regulation in the gut","volume":"14","author":"Zhou","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1124\/jpet.113.203364_bib55","doi-asserted-by":"crossref","first-page":"E1160","DOI":"10.1152\/ajpendo.90637.2008","article-title":"Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents","volume":"295","author":"Zhou","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.203364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:21:17Z","timestamp":1739985677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524185849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0022356524185849"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.203364","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium\/Glucose Cotransporter 1 (SGLT1)\u2013Mediated Absorption of Intestinal Glucose","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.203364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}